Co-occurring gland angularity in localized subgraphs: Predicting biochemical recurrence in intermediate-risk prostate cancer patients

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Lee, George ^a   Sparks, Rachel ^b   Ali, Sahirzeeshan ^a   Shih, Natalie N C ^c   Feldman, Michael D ^c   Spangler, Elaine ^c   Rebbeck, Timothy ^c   Tomaszewski, John E ^d   Madabhushi, Anant ^a  

^a Case Western Reserve University   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOCHEMICAL RECURRENCE; CANCER MORPHOLOGY; CANCER RECURRENCE; CLINICAL ARTICLE; CO OCCURRING GLAND ANGULARITY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; MEASUREMENT ACCURACY; MORPHOMETRICS; PREDICTIVE VALUE; PROSTATE CANCER; PROSTATECTOMY; QUANTITATIVE HISTOMORPHOMETRY; BIOPSY; CANCER GRADING; IMMUNOHISTOCHEMISTRY; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RECURRENT DISEASE; REPRODUCIBILITY; RISK ASSESSMENT; STANDARDS;

BIOPSY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM GRADING; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RECURRENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 84902138072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097954     Document Type: Article

References (31)

1. Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, et al. (2008) Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 299: 2760-2769. (Pubitemid 351846851)
2. Pinto F, Prayer-Galetti T, Gardiman M, Sacco E, Ciaccia M, et al. (2006) Clinical and pathological characteristics of patients presenting with biochemical progression after radical retropubic prostatectomy for pathologically organ-confined prostate cancer. Urol Int 76: 202-208.
3. D'Amico AV, Chen MH, Roehl KA, Catalona WJ (2004) Preoperative psa velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351: 125-135.
4. Epstein JI (2010) An update of the gleason grading system. Journal Of Urology (the) 183: 433.
5. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, et al. (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169: 517-523. (Pubitemid 36132976)
6. Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, et al. (2009) Gleason score and lethal prostate cancer: does 3+4 = 4+3? J Clin Oncol 27: 3459-3464.
7. Allsbrook W Jr, Mangold KA, Johnson MH, Lane RB, Lane CG, et al. (2001) Interobserver reproducibility of gleason grading of prostatic carcinoma: general pathologist. Hum Pathol 32: 81-88. (Pubitemid 32150632)
8. Kattan MW, Wheeler TM, Scardino PT (1999) Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. Journal of Clinical Oncology 17: 1499-1499.
9. Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ, Dotan ZA, et al. (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. Journal of Clinical Oncology 23: 7005-7012.
10. Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC, et al. (2006) Multiinstitutional validation of the ucsf cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer 107: 2384-2391. (Pubitemid 44748521)
11. Hinev A, Anakievski D, Kolev N, Marianovski V, Hadjiev V (2011) Validation of pre-and postoperative nomograms used to predict the pathological stage and prostate cancer recurrence after radical prostatectomy: a multi-institutional study. Journal of BU ON: official journal of the Balkan Union of Oncology 16: 316.
12. Gurcan MN, Boucheron LE, Can A, Madabhushi A, Rajpoot NM, et al. (2009) Histopathological image analysis: a review. IEEE Rev Biomed Eng 2: 147-171.
13. Monaco JP, Tomaszewski JE, Feldman MD, Hagemann I, Moradi M, et al. (2010) High-throughput detection of prostate cancer in histological sections using probabilistic pairwise markov models. Med Image Anal 14: 617-629.
14. Jafari-Khouzani K, Soltanian-Zadeh H (2003) Multiwavelet grading of pathological images of prostate. IEEE Trans on Biomedical Engineering 50: 697-704. (Pubitemid 36723603)
15. Haralick R, Shanmugam K, Dinstein I (1973) Textural features for image classification. IEE Transactions on Systems, Man and Cybernetics 3: 610-621.
16. Doyle S, Feldman MD, Shih N, Tomaszewski J, Madabhushi A (2012) Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer. BMC bioinformatics 13: 282.
17. Tabesh A, Teverovskiy M, Pang HY, Kumar VP, Verbel D, et al. (2007) Multifeature prostate cancer diagnosis and gleason grading of histological images. IEEE Trans Med Imaging 26: 1366-1378. (Pubitemid 47525298)
18. Veltri RW, Isharwal S, Miller MC, Epstein JI, Partin AW (2010) Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy. Prostate 70: 1333-1339.
19. Christens-Barry W, Partin A (1997) Quantitative grading of tissue and nuclei in prostate cancer for prognosis prediction. Johns Hopkins Apl Technical Digest 18: 226-233.
20. Bilgin C, Demir C, Nagi C, Yener B (2007) Cell-graph mining for breast tissue modeling and classification. Conf Proc IEEE Eng Med Biol Soc 2007: 5311-5314.
21. Ali S, Madabhushi A (2012) An integrated region-, boundary-, shape-based active contour for multiple object overlap resolution in histological imagery. IEEE Transactions on Medical Imaging 31: 1448-1460.
22. Ali S, Veltri R, Epstein JI, Christudass C, Madabhushi A (2013) Cell cluster graph for prediction of biochemical recurrence in prostate cancer patients from tissue microarrays. In: Proc. SPIE 8676, Medical Imaging. Digital Pathology.
23. Gunduz C, Yener B, Gultekin SH (2004) The cell graphs of cancer. Bioinformatics 20 Suppl 1: i145-i151. (Pubitemid 41296683)
24. Gunduz-Demir C (2007) Mathematical modeling of the malignancy of cancer using graph evolution. Math Biosci 209: 514-527.
25. Demir C, Gultekin SH, Yener B (2005) Augmented cell-graphs for automated cancer diagnosis. Bioinformatics 21 Suppl 2: ii7-i12.
26. Lee G, Sparks R, Ali S, Madabhushi A, Feldman MD, et al. (2013) Co-occurring gland tensors in localized cluster graphs: Quantitative histomorphometry for predicting biochemical recurrence for intermediate grade prostate cancer. In: Biomedical Imaging (ISBI), 2013 IEEE 10th International Symposium on. IEEE, 113-116.
27. Hotelling H (1933) Analysis of a complex of statistical variables into principal components. Journal of educational psychology 24: 417.
28. Breiman L (2001) Random forests. Machine learning 45: 5-32.
29. Fagerland MW (2012) t-tests, non-parametric tests, and large studiesa paradox of statistical practice? BMC Medical Research Methodology 12: 78.
30. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. Journal of the American statistical association 53: 457-481.
31. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170.